Structure

Physi-Chem Properties

Molecular Weight:  372.08
Volume:  358.104
LogP:  1.501
LogD:  1.386
LogS:  -3.33
# Rotatable Bonds:  4
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.44
Synthetic Accessibility Score:  3.739
Fsp3:  0.211
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.727
MDCK Permeability:  8.537049325241242e-06
Pgp-inhibitor:  0.008
Pgp-substrate:  0.031
Human Intestinal Absorption (HIA):  0.22
20% Bioavailability (F20%):  0.298
30% Bioavailability (F30%):  0.322

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.062
Plasma Protein Binding (PPB):  81.82006072998047%
Volume Distribution (VD):  0.451
Pgp-substrate:  24.605817794799805%

ADMET: Metabolism

CYP1A2-inhibitor:  0.033
CYP1A2-substrate:  0.37
CYP2C19-inhibitor:  0.118
CYP2C19-substrate:  0.295
CYP2C9-inhibitor:  0.221
CYP2C9-substrate:  0.437
CYP2D6-inhibitor:  0.005
CYP2D6-substrate:  0.116
CYP3A4-inhibitor:  0.295
CYP3A4-substrate:  0.567

ADMET: Excretion

Clearance (CL):  1.644
Half-life (T1/2):  0.46

ADMET: Toxicity

hERG Blockers:  0.04
Human Hepatotoxicity (H-HT):  0.085
Drug-inuced Liver Injury (DILI):  0.702
AMES Toxicity:  0.275
Rat Oral Acute Toxicity:  0.132
Maximum Recommended Daily Dose:  0.014
Skin Sensitization:  0.081
Carcinogencity:  0.059
Eye Corrosion:  0.003
Eye Irritation:  0.016
Respiratory Toxicity:  0.023

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC256162

Natural Product ID:  NPC256162
Common Name*:   (+)-Tylopilusin B
IUPAC Name:   methyl (1R,5R)-1,3,5-trihydroxy-2,5-bis(4-hydroxyphenyl)-4-oxocyclopent-2-ene-1-carboxylate
Synonyms:   (+)-Tylopilusin B
Standard InCHIKey:  IRFBODXJISNYDS-OALUTQOASA-N
Standard InCHI:  InChI=1S/C19H16O8/c1-27-17(24)19(26)14(10-2-6-12(20)7-3-10)15(22)16(23)18(19,25)11-4-8-13(21)9-5-11/h2-9,20-22,25-26H,1H3/t18-,19-/m0/s1
SMILES:  COC(=O)[C@@]1(O)C(=C(C(=O)[C@@]1(O)c1ccc(cc1)O)O)c1ccc(cc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2208232
PubChem CID:   71463266
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000134] Phenols
        • [CHEMONTID:0004646] 1-hydroxy-2-unsubstituted benzenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32559 tylopilus eximius Species Boletaceae Eukaryota fruiting bodies n.a. n.a. PMID[23215444]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus IZ = 7.0 mm PMID[514760]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC256162 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC59775
0.9706 High Similarity NPC32
0.9706 High Similarity NPC122491
0.8417 Intermediate Similarity NPC108553
0.838 Intermediate Similarity NPC255428
0.8231 Intermediate Similarity NPC474692
0.8207 Intermediate Similarity NPC156709
0.8207 Intermediate Similarity NPC179505
0.8188 Intermediate Similarity NPC229264
0.8153 Intermediate Similarity NPC164937
0.8146 Intermediate Similarity NPC44378
0.8146 Intermediate Similarity NPC280753
0.8146 Intermediate Similarity NPC32197
0.8102 Intermediate Similarity NPC14141
0.8079 Intermediate Similarity NPC94781
0.8069 Intermediate Similarity NPC67349
0.8069 Intermediate Similarity NPC279676
0.8056 Intermediate Similarity NPC233350
0.8056 Intermediate Similarity NPC182217
0.8056 Intermediate Similarity NPC70680
0.803 Intermediate Similarity NPC221870
0.8026 Intermediate Similarity NPC240592
0.8026 Intermediate Similarity NPC117346
0.8014 Intermediate Similarity NPC214246
0.7986 Intermediate Similarity NPC68517
0.7949 Intermediate Similarity NPC475378
0.7947 Intermediate Similarity NPC221383
0.7947 Intermediate Similarity NPC283081
0.7947 Intermediate Similarity NPC299090
0.7947 Intermediate Similarity NPC322660
0.7947 Intermediate Similarity NPC143892
0.7943 Intermediate Similarity NPC217431
0.7935 Intermediate Similarity NPC477299
0.7926 Intermediate Similarity NPC104514
0.7917 Intermediate Similarity NPC471749
0.7911 Intermediate Similarity NPC130489
0.7911 Intermediate Similarity NPC208676
0.7908 Intermediate Similarity NPC120171
0.7905 Intermediate Similarity NPC136649
0.7899 Intermediate Similarity NPC68167
0.7899 Intermediate Similarity NPC469927
0.7899 Intermediate Similarity NPC139171
0.7895 Intermediate Similarity NPC192568
0.7895 Intermediate Similarity NPC471076
0.7891 Intermediate Similarity NPC283560
0.7891 Intermediate Similarity NPC24295
0.7881 Intermediate Similarity NPC205389
0.7875 Intermediate Similarity NPC161151
0.7867 Intermediate Similarity NPC304956
0.7867 Intermediate Similarity NPC183824
0.7862 Intermediate Similarity NPC106406
0.7857 Intermediate Similarity NPC127975
0.7857 Intermediate Similarity NPC289021
0.7857 Intermediate Similarity NPC158546
0.7847 Intermediate Similarity NPC327204
0.7847 Intermediate Similarity NPC323379
0.7843 Intermediate Similarity NPC161955
0.7843 Intermediate Similarity NPC96599
0.7842 Intermediate Similarity NPC236981
0.7838 Intermediate Similarity NPC474875
0.7838 Intermediate Similarity NPC205751
0.7838 Intermediate Similarity NPC26241
0.7838 Intermediate Similarity NPC476820
0.7838 Intermediate Similarity NPC295492
0.7838 Intermediate Similarity NPC274891
0.7838 Intermediate Similarity NPC476819
0.7838 Intermediate Similarity NPC242355
0.7838 Intermediate Similarity NPC303683
0.7834 Intermediate Similarity NPC123208
0.7815 Intermediate Similarity NPC210330
0.7815 Intermediate Similarity NPC53884
0.7815 Intermediate Similarity NPC258671
0.7806 Intermediate Similarity NPC478235
0.7806 Intermediate Similarity NPC95498
0.7806 Intermediate Similarity NPC205918
0.7806 Intermediate Similarity NPC246566
0.78 Intermediate Similarity NPC186296
0.78 Intermediate Similarity NPC277315
0.78 Intermediate Similarity NPC258469
0.78 Intermediate Similarity NPC285550
0.78 Intermediate Similarity NPC43158
0.78 Intermediate Similarity NPC192831
0.78 Intermediate Similarity NPC472016
0.7793 Intermediate Similarity NPC202743
0.7793 Intermediate Similarity NPC477281
0.7793 Intermediate Similarity NPC215484
0.7793 Intermediate Similarity NPC155209
0.7793 Intermediate Similarity NPC168799
0.7793 Intermediate Similarity NPC19719
0.7793 Intermediate Similarity NPC164172
0.7793 Intermediate Similarity NPC477280
0.7792 Intermediate Similarity NPC35097
0.7786 Intermediate Similarity NPC231767
0.7785 Intermediate Similarity NPC137501
0.7785 Intermediate Similarity NPC159387
0.7785 Intermediate Similarity NPC154262
0.7785 Intermediate Similarity NPC329997
0.7785 Intermediate Similarity NPC7518
0.7778 Intermediate Similarity NPC25484
0.7778 Intermediate Similarity NPC232583
0.777 Intermediate Similarity NPC302857
0.777 Intermediate Similarity NPC142703
0.777 Intermediate Similarity NPC152942
0.777 Intermediate Similarity NPC219428
0.777 Intermediate Similarity NPC37250
0.777 Intermediate Similarity NPC278068
0.7763 Intermediate Similarity NPC143246
0.7763 Intermediate Similarity NPC474268
0.7763 Intermediate Similarity NPC473147
0.7763 Intermediate Similarity NPC119773
0.7763 Intermediate Similarity NPC475539
0.7756 Intermediate Similarity NPC229354
0.7755 Intermediate Similarity NPC475955
0.7755 Intermediate Similarity NPC474726
0.7748 Intermediate Similarity NPC202391
0.7748 Intermediate Similarity NPC296659
0.7742 Intermediate Similarity NPC477100
0.7742 Intermediate Similarity NPC474620
0.7742 Intermediate Similarity NPC477098
0.7736 Intermediate Similarity NPC329743
0.7733 Intermediate Similarity NPC253481
0.7733 Intermediate Similarity NPC477335
0.7733 Intermediate Similarity NPC224389
0.7733 Intermediate Similarity NPC148080
0.7733 Intermediate Similarity NPC469623
0.7733 Intermediate Similarity NPC206095
0.7733 Intermediate Similarity NPC35702
0.7733 Intermediate Similarity NPC253722
0.7733 Intermediate Similarity NPC471027
0.7733 Intermediate Similarity NPC45307
0.7733 Intermediate Similarity NPC31751
0.7733 Intermediate Similarity NPC297517
0.7733 Intermediate Similarity NPC13818
0.7727 Intermediate Similarity NPC478236
0.7727 Intermediate Similarity NPC478234
0.7724 Intermediate Similarity NPC25581
0.7724 Intermediate Similarity NPC18074
0.7724 Intermediate Similarity NPC61
0.7724 Intermediate Similarity NPC471095
0.7724 Intermediate Similarity NPC173034
0.7724 Intermediate Similarity NPC471066
0.7724 Intermediate Similarity NPC5419
0.7718 Intermediate Similarity NPC475413
0.7718 Intermediate Similarity NPC473497
0.7718 Intermediate Similarity NPC474303
0.7708 Intermediate Similarity NPC470122
0.7708 Intermediate Similarity NPC17968
0.7708 Intermediate Similarity NPC469705
0.7704 Intermediate Similarity NPC23402
0.7703 Intermediate Similarity NPC170718
0.7703 Intermediate Similarity NPC308976
0.7702 Intermediate Similarity NPC322982
0.7697 Intermediate Similarity NPC475528
0.7692 Intermediate Similarity NPC471229
0.7692 Intermediate Similarity NPC158673
0.7688 Intermediate Similarity NPC73422
0.7688 Intermediate Similarity NPC310399
0.7682 Intermediate Similarity NPC319628
0.7682 Intermediate Similarity NPC284948
0.7682 Intermediate Similarity NPC303090
0.7682 Intermediate Similarity NPC37331
0.7682 Intermediate Similarity NPC89317
0.7682 Intermediate Similarity NPC220664
0.7677 Intermediate Similarity NPC277032
0.7673 Intermediate Similarity NPC473395
0.7667 Intermediate Similarity NPC477279
0.7667 Intermediate Similarity NPC469911
0.7664 Intermediate Similarity NPC471033
0.7664 Intermediate Similarity NPC311091
0.7662 Intermediate Similarity NPC189631
0.7662 Intermediate Similarity NPC1580
0.7662 Intermediate Similarity NPC120728
0.766 Intermediate Similarity NPC85565
0.7658 Intermediate Similarity NPC317585
0.7658 Intermediate Similarity NPC471456
0.7655 Intermediate Similarity NPC198388
0.7655 Intermediate Similarity NPC476407
0.7651 Intermediate Similarity NPC31745
0.7651 Intermediate Similarity NPC220936
0.7643 Intermediate Similarity NPC210597
0.7643 Intermediate Similarity NPC257847
0.764 Intermediate Similarity NPC90336
0.7639 Intermediate Similarity NPC469549
0.7635 Intermediate Similarity NPC475549
0.7632 Intermediate Similarity NPC251062
0.7632 Intermediate Similarity NPC184464
0.7632 Intermediate Similarity NPC194938
0.7632 Intermediate Similarity NPC470130
0.7628 Intermediate Similarity NPC267117
0.7628 Intermediate Similarity NPC56204
0.7628 Intermediate Similarity NPC315520
0.7625 Intermediate Similarity NPC209473
0.7619 Intermediate Similarity NPC474895
0.7616 Intermediate Similarity NPC477275
0.7616 Intermediate Similarity NPC477278
0.7616 Intermediate Similarity NPC477277
0.7616 Intermediate Similarity NPC82467
0.761 Intermediate Similarity NPC10945
0.7607 Intermediate Similarity NPC88243
0.76 Intermediate Similarity NPC191280

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC256162 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7682 Intermediate Similarity NPD6190 Approved
0.7586 Intermediate Similarity NPD3764 Approved
0.7453 Intermediate Similarity NPD7075 Discontinued
0.7386 Intermediate Similarity NPD4628 Phase 3
0.7368 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD6799 Approved
0.7308 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD6599 Discontinued
0.7273 Intermediate Similarity NPD6232 Discontinued
0.7267 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD943 Approved
0.7246 Intermediate Similarity NPD7473 Discontinued
0.7237 Intermediate Similarity NPD2935 Discontinued
0.7235 Intermediate Similarity NPD7685 Pre-registration
0.7222 Intermediate Similarity NPD3817 Phase 2
0.7205 Intermediate Similarity NPD6801 Discontinued
0.72 Intermediate Similarity NPD6355 Discontinued
0.7192 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD4380 Phase 2
0.7178 Intermediate Similarity NPD3882 Suspended
0.7163 Intermediate Similarity NPD9545 Approved
0.7134 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD1240 Approved
0.7133 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD1164 Approved
0.7123 Intermediate Similarity NPD1470 Approved
0.7086 Intermediate Similarity NPD230 Phase 1
0.7075 Intermediate Similarity NPD5647 Approved
0.7067 Intermediate Similarity NPD6233 Phase 2
0.7067 Intermediate Similarity NPD6663 Approved
0.7059 Intermediate Similarity NPD2799 Discontinued
0.7059 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1510 Phase 2
0.7059 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD2801 Approved
0.7039 Intermediate Similarity NPD1607 Approved
0.703 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD8434 Phase 2
0.7027 Intermediate Similarity NPD5736 Approved
0.7019 Intermediate Similarity NPD3226 Approved
0.7013 Intermediate Similarity NPD5405 Approved
0.7013 Intermediate Similarity NPD5404 Approved
0.7013 Intermediate Similarity NPD5406 Approved
0.7013 Intermediate Similarity NPD5408 Approved
0.7012 Intermediate Similarity NPD5402 Approved
0.7 Intermediate Similarity NPD5403 Approved
0.7 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6798 Discontinued
0.6994 Remote Similarity NPD1934 Approved
0.6987 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6985 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6166 Phase 2
0.6982 Remote Similarity NPD6167 Clinical (unspecified phase)
0.697 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6968 Remote Similarity NPD2344 Approved
0.6968 Remote Similarity NPD7266 Discontinued
0.6966 Remote Similarity NPD1201 Approved
0.6966 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6951 Remote Similarity NPD7819 Suspended
0.6948 Remote Similarity NPD7033 Discontinued
0.6944 Remote Similarity NPD3019 Approved
0.6944 Remote Similarity NPD2932 Approved
0.6943 Remote Similarity NPD3400 Discontinued
0.6943 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6943 Remote Similarity NPD3750 Approved
0.6939 Remote Similarity NPD1876 Approved
0.6937 Remote Similarity NPD1512 Approved
0.6933 Remote Similarity NPD7095 Approved
0.6933 Remote Similarity NPD7411 Suspended
0.6932 Remote Similarity NPD8150 Discontinued
0.6928 Remote Similarity NPD3749 Approved
0.6923 Remote Similarity NPD970 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1608 Approved
0.6918 Remote Similarity NPD9269 Phase 2
0.6918 Remote Similarity NPD7390 Discontinued
0.6901 Remote Similarity NPD3818 Discontinued
0.6901 Remote Similarity NPD9493 Approved
0.6899 Remote Similarity NPD2354 Approved
0.6897 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6894 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6892 Remote Similarity NPD3094 Phase 2
0.6887 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6887 Remote Similarity NPD3268 Approved
0.6879 Remote Similarity NPD2629 Approved
0.6875 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2534 Approved
0.6875 Remote Similarity NPD2532 Approved
0.6875 Remote Similarity NPD2533 Approved
0.6875 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6875 Remote Similarity NPD5401 Approved
0.6859 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6859 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6859 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6859 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6859 Remote Similarity NPD6005 Phase 3
0.6859 Remote Similarity NPD6004 Phase 3
0.6859 Remote Similarity NPD6002 Phase 3
0.6855 Remote Similarity NPD3300 Phase 2
0.6842 Remote Similarity NPD4062 Phase 3
0.6842 Remote Similarity NPD3020 Approved
0.6838 Remote Similarity NPD5048 Discontinued
0.6835 Remote Similarity NPD8166 Discontinued
0.6824 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6653 Approved
0.6815 Remote Similarity NPD1549 Phase 2
0.6813 Remote Similarity NPD1511 Approved
0.6807 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6797 Remote Similarity NPD4060 Phase 1
0.6792 Remote Similarity NPD2309 Approved
0.6788 Remote Similarity NPD37 Approved
0.6786 Remote Similarity NPD6234 Discontinued
0.6784 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6783 Remote Similarity NPD405 Clinical (unspecified phase)
0.6782 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6782 Remote Similarity NPD6797 Phase 2
0.6781 Remote Similarity NPD4136 Approved
0.6781 Remote Similarity NPD4135 Approved
0.6781 Remote Similarity NPD4106 Approved
0.6779 Remote Similarity NPD2797 Approved
0.6776 Remote Similarity NPD2313 Discontinued
0.6766 Remote Similarity NPD7768 Phase 2
0.6763 Remote Similarity NPD3022 Approved
0.6763 Remote Similarity NPD3021 Approved
0.6759 Remote Similarity NPD9268 Approved
0.6759 Remote Similarity NPD4105 Approved
0.6759 Remote Similarity NPD4102 Approved
0.6757 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6752 Remote Similarity NPD5763 Approved
0.6752 Remote Similarity NPD5762 Approved
0.675 Remote Similarity NPD7236 Approved
0.6747 Remote Similarity NPD7972 Discontinued
0.6743 Remote Similarity NPD7251 Discontinued
0.6743 Remote Similarity NPD6559 Discontinued
0.6742 Remote Similarity NPD2860 Approved
0.6742 Remote Similarity NPD2859 Approved
0.6733 Remote Similarity NPD2798 Approved
0.6725 Remote Similarity NPD3926 Phase 2
0.6724 Remote Similarity NPD7074 Phase 3
0.6712 Remote Similarity NPD5306 Approved
0.6712 Remote Similarity NPD5305 Approved
0.6712 Remote Similarity NPD17 Approved
0.6711 Remote Similarity NPD1283 Approved
0.6709 Remote Similarity NPD4534 Discontinued
0.6709 Remote Similarity NPD5958 Discontinued
0.6707 Remote Similarity NPD7458 Discontinued
0.6706 Remote Similarity NPD7199 Phase 2
0.6705 Remote Similarity NPD7799 Discontinued
0.6705 Remote Similarity NPD3751 Discontinued
0.6705 Remote Similarity NPD7808 Phase 3
0.6691 Remote Similarity NPD74 Approved
0.6691 Remote Similarity NPD9266 Approved
0.6689 Remote Similarity NPD3972 Approved
0.6689 Remote Similarity NPD1481 Phase 2
0.6688 Remote Similarity NPD2796 Approved
0.6688 Remote Similarity NPD1551 Phase 2
0.6687 Remote Similarity NPD3887 Approved
0.6686 Remote Similarity NPD5953 Discontinued
0.6667 Remote Similarity NPD7054 Approved
0.6667 Remote Similarity NPD4966 Approved
0.6667 Remote Similarity NPD2933 Approved
0.6667 Remote Similarity NPD4967 Phase 2
0.6667 Remote Similarity NPD7028 Phase 2
0.6667 Remote Similarity NPD1203 Approved
0.6667 Remote Similarity NPD3847 Discontinued
0.6667 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4965 Approved
0.6667 Remote Similarity NPD2934 Approved
0.6667 Remote Similarity NPD2800 Approved
0.6647 Remote Similarity NPD1465 Phase 2
0.6647 Remote Similarity NPD8455 Phase 2
0.6646 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6646 Remote Similarity NPD7239 Suspended
0.6646 Remote Similarity NPD2353 Approved
0.6646 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6646 Remote Similarity NPD2346 Discontinued
0.6645 Remote Similarity NPD4340 Discontinued
0.6645 Remote Similarity NPD6832 Phase 2
0.6644 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6643 Remote Similarity NPD2067 Discontinued
0.6629 Remote Similarity NPD7472 Approved
0.6626 Remote Similarity NPD5049 Phase 3
0.6626 Remote Similarity NPD6273 Approved
0.6625 Remote Similarity NPD2575 Approved
0.6624 Remote Similarity NPD3748 Approved
0.6624 Remote Similarity NPD3299 Clinical (unspecified phase)
0.6622 Remote Similarity NPD4807 Approved
0.6622 Remote Similarity NPD4806 Approved
0.6622 Remote Similarity NPD1535 Discovery
0.6622 Remote Similarity NPD3092 Approved
0.6619 Remote Similarity NPD9267 Approved
0.6619 Remote Similarity NPD9263 Approved
0.6619 Remote Similarity NPD9264 Approved
0.6612 Remote Similarity NPD6534 Approved
0.6612 Remote Similarity NPD6535 Approved
0.6604 Remote Similarity NPD2424 Discontinued
0.6601 Remote Similarity NPD3027 Phase 3
0.6597 Remote Similarity NPD4198 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data